Skip to results
Modify your search
NARROW
1-20 of 40
Authors: Muthiah Vaduganathan
Journal Article
Integrating ketone bodies in multi-marker risk prediction of incident heart failure in the multi-ethnic study of atherosclerosis
European Journal of Preventive Cardiology, zwaf168, https://doi.org/10.1093/eurjpc/zwaf168
Published: 21 March 2025
Journal Article
Obesity management: a foundational cardiovascular health priority Get access
European Journal of Preventive Cardiology, zwaf043, https://doi.org/10.1093/eurjpc/zwaf043
Published: 06 February 2025
Journal Article
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
European Heart Journal, ehaf057, https://doi.org/10.1093/eurheartj/ehaf057
Published: 28 January 2025
Journal Article
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1321–1331, https://doi.org/10.1093/eurheartj/ehae780
Published: 21 November 2024
Journal Article
Implementing medical therapy during worsening heart failure
European Heart Journal, Volume 45, Issue 42, 7 November 2024, Pages 4494–4496, https://doi.org/10.1093/eurheartj/ehae566
Published: 31 August 2024
Journal Article
STEPping down diuretic therapy with semaglutide in obesity-related heart failure with preserved ejection fraction: decongestion or disease modification? Get access
European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3270–3273, https://doi.org/10.1093/eurheartj/ehae410
Published: 26 July 2024
Journal Article
Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study Get access
European Journal of Preventive Cardiology, Volume 32, Issue 3, February 2025, Pages 259–261, https://doi.org/10.1093/eurjpc/zwae224
Published: 18 July 2024
Journal Article
Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists Get access
European Heart Journal, Volume 45, Issue 30, 7 August 2024, Pages 2748–2751, https://doi.org/10.1093/eurheartj/ehae414
Published: 10 July 2024
Journal Article
EDITOR'S CHOICE
Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial
European Heart Journal, Volume 45, Issue 20, 21 May 2024, Pages 1856–1858, https://doi.org/10.1093/eurheartj/ehae235
Published: 10 April 2024
Journal Article
EDITOR'S CHOICE
Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome
European Journal of Preventive Cardiology, Volume 31, Issue 5, March 2024, Pages 615–626, https://doi.org/10.1093/eurjpc/zwad373
Published: 06 December 2023
Journal Article
Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 68–80, https://doi.org/10.1093/ehjcvp/pvad067
Published: 22 September 2023
Journal Article
Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy Registry
European Heart Journal, Volume 44, Issue 44, 21 November 2023, Pages 4650–4661, https://doi.org/10.1093/eurheartj/ehad584
Published: 26 August 2023
Journal Article
EDITOR'S CHOICE
Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2216–2230, https://doi.org/10.1093/eurheartj/ehad273
Published: 01 June 2023
Journal Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2930–2943, https://doi.org/10.1093/eurheartj/ehad283
Published: 23 May 2023
Journal Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170–2183, https://doi.org/10.1093/eurheartj/ehad276
Published: 23 May 2023
Journal Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2982–2993, https://doi.org/10.1093/eurheartj/ehad344
Published: 21 May 2023
Journal Article
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials
European Heart Journal, Volume 44, Issue 21, 1 June 2023, Pages 1890–1909, https://doi.org/10.1093/eurheartj/ehad171
Published: 26 April 2023
Journal Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2202–2212, https://doi.org/10.1093/eurheartj/ehad210
Published: 13 April 2023
Journal Article
EDITOR'S CHOICE
Circulating ketone bodies and cardiovascular outcomes: the MESA study
European Heart Journal, Volume 44, Issue 18, 7 May 2023, Pages 1636–1646, https://doi.org/10.1093/eurheartj/ehad087
Published: 06 March 2023
Journal Article
A rationale for dedicated trials of combination therapy in heart failure
European Heart Journal Supplements, Volume 24, Issue Supplement_L, December 2022, Pages L49–L52, https://doi.org/10.1093/eurheartjsupp/suac116
Published: 19 December 2022
